OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
60
Views
19
CrossRef citations to date
0
Altmetric
Review
Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib
Ittai B Muller1 Department of Clinical Chemistry
, Adrianus J de Langen2 Department of Pulmonology, VU University Medical Center;3 Department of Thoracic Oncology, Netherlands Cancer Institute
, Elisa Giovannetti4 Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands;5 Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
& Godefridus J Peters4 Department of Medical Oncology, VU University Medical Center, Amsterdam, the NetherlandsCorrespondence[email protected]
Pages 4535-4541
|
Published online: 13 Sep 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.